For over a decade, Illumina has maintained a strong leadership position in the field of Next-Generation Sequencing (NGS). This dominance is largely attributed to its robust Sequencing by Synthesis (SBS) technology, a diverse portfolio of platforms catering to a wide spectrum of research needs, and a comprehensive ecosystem of readily available reagents and user-friendly analysis […]

View Entire Post